… treatment regimens with meglumine antimoniate (MA), in a reference center in Rio de Janeiro,
Brazil. … Meglumine antimoniate (MA) in different regimens was evaluated in cutaneous …

… meglumine antimoniate for treatment of cutaneous leishmaniasis patients with contraindication
to systemic therapy from Rio de Janeiro (… antimony in Rio de Janeiro, Brazilian area of …

… Moreover, a phase III randomised controlled, non-inferiority, blind trial conducted in Rio
de Janeiro between 2008 and 2014 37 revealed that a clinical cure rate of 77.8% of subjects …

… treatment with 5 mg Sb v /kg/day meglumine antimoniate (MA) has been reported in Rio de
… ATL in Brazilian states other than Rio de Janeiro (OS group) and 72 patients from Rio de …

… The leishmanicidal activity of four batches of meglumine antimoniate, produced in … The
meglumine antimoniate produced by Farmanguinhos was as effective as the reference …

… The drug of choice for treatment is meglumine antimoniate (Glucantime ® ). The aim of
this study was to evaluate patients with visceral leishmaniasis according to criteria used for …

… We evaluated the effectiveness and safety of intralesional meglumine antimoniate (MA) in
24 not submitted to previous treatment patients with cutaneous leishmaniasis (CL) and with …

… Rio de Janeiro, Brazil. At this institution, intralesional (IL) treatment with meglumine antimoniate
… cutaneous leishmaniasis with pentavalent antimony in Rio de Janeiro, Brazil - an area of …

SciELO - Brasil - Meglumine antimoniate intralesional infiltration for localised cutaneous
leishmaniasis: a single arm, open label, phase II clinical trial Meglumine antimoniate …

… O esquema de tratamento antimonial intermitente é superior ao contínuo na terapia da
leishmaniose cutânea no município do Rio de Janeiro, Brasil. Revista da Sociedade Brasileira …